Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis

One third of the world is infected with Mycobacterium tuberculosis (Mtb) with eight million new cases of active tuberculosis (TB) each year. Development of a new vaccine to augment or replace the only approved TB vaccine, BCG, is needed to control this disease. Mtb infection is primarily controlled...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Orr, Mark T., Fox, Christopher B., Baldwin, Susan L., Sivananthan, Sandra J., Lucas, Elyse, Lin, Susan, Phan, Tony, Moon, James J., Vedvick, Thomas S., Reed, Steven G., Coler, Rhea N.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3871206/
https://ncbi.nlm.nih.gov/pubmed/23933525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2013.07.030
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg